You are here

Home

Wyeth

Well-Hidden Perk Adds Up To Big Money for Executives

Deferred-Compensation Plans Give Tax Benefits, But Are Poorly Disclosed and Add to Liability
The Wall Street Journal
Original publication date: 
Friday, October 11, 2002 - 00:00

Last year, John R. Stafford, chairman of pharmaceutical giant Wyeth, earned $1.8 million in salary. He also was awarded a $1.97 million bonus, restricted stock valued at $724,283 and 630,000 stock options.

That much shareholders can learn from glancing at the company's proxy.

Subscribe to RSS - Wyeth

Identity proofs: @theofrancis@mastodon.online

Powered by Drupal